Randomized controlled trial of integrated traditional Chinese and western medicine treatment for posthepatitic cirrhotic ascites: a systematic review.
- VernacularTitle:中西医结合治疗肝炎后肝硬化腹水随机对照试验的质量评价
- Author:
Lei CHEN
1
;
Zhi-Ping LU
Author Information
- Publication Type:Journal Article
- MeSH: Ascites; drug therapy; etiology; Drugs, Chinese Herbal; therapeutic use; Hepatitis; complications; Humans; Medicine, Chinese Traditional; Phytotherapy; Randomized Controlled Trials as Topic; Treatment Outcome
- From: Chinese Journal of Hepatology 2011;19(3):205-209
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo research domestic general situation and quality of the clinical treatment of posthepatitic cirrhotic ascites in Integrated Traditional Chinese and Western Medicine.
METHODSChose CNKI, VIP, Wang fang and CBM as data source and searched the literature of the clinical treatment of posthepatitic cirrhotic ascites in Integrated Traditional Chinese and Western Medicine which published officially from January 1980 to January 2010 and which received a Jaded score of 2 or greater to do a systematic evaluation, including the description of subjects, study design and methods, therapeutic efficacy and statistical methods.
RESULTS136 articles in all met inclusion criteria and 58 articles which received a Jaded score of 2 or greater did this research. The main problems of domestic posthepatitic cirrhotic ascites in Integrated Traditional Chinese and Western Medicine in 30 years included: randomized controlled trial design was unreasonable, lack of blinding, lack of standardized criteria, the sample size was small and lack of specific estimation methods, lack of compliance, case off and withdraw, ignoring adverse reaction and the research of life quality.
CONCLUSIONThe clinical treatment of posthepatitic cirrhotic ascites in Integrated Traditional Chinese and Western Medicine have a "personalized" and "diversity" character and the methods and standards of clinical research need to be improved.